Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
129,821,091
-
Total 13F shares
-
39,818,774
-
Share change
-
+5,253,427
-
Total reported value
-
$445,584,614
-
Put/Call ratio
-
7.6%
-
Price per share
-
$11.19
-
Number of holders
-
56
-
Value change
-
+$58,753,645
-
Number of buys
-
47
-
Number of sells
-
9
Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q2 2023
As of 30 Jun 2023,
PROKIDNEY CORP. - Ordinary Shares (PROK) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,818,774 shares.
The largest 10 holders included
Social Capital Group LLC, MORGAN STANLEY, BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Bleichroeder LP, Brown University, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.